Epigenetic alterations in peripheral blood cell DNA and implications for breast cancer detection, prognosis, and treatment.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e13619-e13619
Author(s):  
B. Torres-Torres ◽  
J. Martínez-Galán ◽  
R. Del Moral ◽  
M. Núñez ◽  
B. González-Astorga ◽  
...  
2020 ◽  
Vol 56 (20) ◽  
pp. 3050-3053
Author(s):  
Meng-Xian Liu ◽  
Shuai Chen ◽  
Na Ding ◽  
Yong-Liang Yu ◽  
Jian-Hua Wang

A carbon-based polymer dot (CPD) sensor can quickly and accurately detect cancer mice using peripheral blood immunocytes.


Pteridines ◽  
2013 ◽  
Vol 24 (3) ◽  
pp. 211-217 ◽  
Author(s):  
Vlastislav Šrámek ◽  
Bohuslav Melichar ◽  
Hana Študentová ◽  
Hana Kalábová ◽  
David Vrána ◽  
...  

AbstractThe aim of the present study was to evaluate the association between changes in peripheral blood cell count and neopterin concentrations in patients with a history of breast cancer. Peripheral blood cell count, serum ferritin, serum neopterin and urinary neopterin concentrations were determined in 61 patients with a history of breast cancer and 74 control subjects. Hemoglobin, relative lymphocyte count and absolute lymphocyte count were lower, and relative neutrophil count, ferritin and serum neopterin concentrations were significantly higher in breast cancer patients than in controls. Compared to controls, the difference in hemoglobin concentration was statistically significant only in patients with active disease. Significant negative correlations were observed between urinary neopterin and hemoglobin as well as between serum neopterin and relative lymphocyte counts in breast cancer patients. Increased ferritin concentrations were associated with a history of hypertension, but higher absolute lymphocyte counts were associated with hypertension only in subjects without history of cancer. In conclusion, in patients with a history of breast cancer, anemia is associated with disease activity and systemic immune activation. Ferritin concentrations are increased in subjects with hypertension.


2019 ◽  
Author(s):  
Chang Ik Yoon ◽  
So Eun Park ◽  
Yoon Jin Cha ◽  
Soong June Bae ◽  
Chi Hwan Cha ◽  
...  

AbstractTumor-infiltrating lymphocytes (TILs) might be associated with host-cell mediated immunity, which could be partly reflected by peripheral blood cell counts. We aimed to investigate whether peripheral blood cell counts are associated with TILs in breast cancer. Between August 2016 and July 2018, we evaluated the percentage of stromal TILs in breast cancer patients who underwent primary surgery, using the standardized methodology proposed by the international TIL Working Group. Lymphocyte-predominant breast cancer (LPBC) was defined as tumors having high TIL levels (≥ 50%). Peripheral blood cell counts including absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC) and neutrophil-to-lymphocyte ratio (NLR) was obtained from pretreatment laboratory data. Of the 684 patients, 99 (17.2%) had LPBC, and 478 (82.8%) had non-LBPC. In a comparison of 3 markers of peripheral blood counts, LPBC had a significantly lower mean ANC than non-LPBC (3,330 vs. 3,660; P=0.004), but the other means were not different. Decreasing ANC was an independent clinical factor in predicting LPBC (OR: 0.736, 95% CI: 0.591-0.917; P=0.004). Low peripheral ANC might be linked with LPBC, supporting the hypothesis that systemic immune cell counts might be associated with the tumor-immune microenvironment.


PLoS ONE ◽  
2008 ◽  
Vol 3 (7) ◽  
pp. e2656 ◽  
Author(s):  
Martin Widschwendter ◽  
Sophia Apostolidou ◽  
Elke Raum ◽  
Dietrich Rothenbacher ◽  
Heidi Fiegl ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document